SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending sharply upwards following exceptionally positive Phase 2 S-OLARIS trial data for sonelokimab in axial spondyloarthritis, which revealed "disease-modifying" potential and robust efficacy. The community is buzzing with expectations for significant upside, fueled by a major institutional buyback, strong financials, and the upcoming Investor Day, intensifying talks of a potential short squeeze and a "best-in-class" valuation.

TOSHI

TOSHI is actively trending across the crypto community, driven by strong technical indicators pointing to an imminent breakout and a prevailing bullish sentiment for its role as a key memecoin within the Base ecosystem. Many investors are seizing current price levels, anticipating a substantial rally as altcoin season gains momentum.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to prevailing community bearishness surrounding new global tariffs and escalating geopolitical tensions, which, coupled with a crypto market downturn, has many anticipating a notable market correction.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

ProShares Short Bitcoin Strategy ETF ($BITI) is trending as community discussion links Jeffrey Epstein to early Bitcoin development, sparking strong bearish sentiment. Many traders are actively shorting Bitcoin, labeling it a 'pedo-currency' and expecting significant price drops.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF ($EWY) is trending as the Kospi index reaches new highs, fueled by its dominant exposure to semiconductor giants like Samsung and SK Hynix, which are driving the AI memory boom. The community is actively discussing its significant outperformance and attractive valuation compared to other global markets.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors react to the dynamic landscape of US-China trade, including recent court rulings that could ease tariffs, while simultaneously focusing on the company's rapid advancements in AI models like Qwen 3.5 and its powerful Zhenwu 810E chip. The community is actively debating whether these developments solidify Alibaba's position as an undervalued growth play, despite lingering geopolitical concerns.

BlackRock Institutional Trust Company N.A. - iShares China Large-Cap ETF

iShares China Large-Cap ETF

FXI is gaining attention as a U.S. court ruling blocking IEEPA levies signals a potential significant reduction in tariffs on Chinese goods, sparking community discussion about a broad trade truce. Many investors see this as a rare window for a rally in the often-oversold China market, even as questions persist regarding the nation's economic stability.

Pump.fun

Pump.fun (PUMP CRYPTO) is experiencing significant market conversation after news broke of a former developer's fraud sentencing and an intensifying lawsuit, fueling both strong calls to "pump it" by loyalists citing platform buybacks, and concerns about its legitimacy among skeptics.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is a trending topic ahead of its earnings report, driven by expectations of strong AI server demand and recent analyst upgrades, although community discussion highlights skepticism and accusations of manipulation surrounding some downgrades amidst concerns about rising memory prices.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is seeing significant attention after reporting blowout earnings, strong guidance, and an ambitious capital expenditure outlook that reaffirms its central role in the AI supercycle, with investors also closely monitoring ongoing U.S.-Taiwan trade discussions that could further impact global chip supply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Skandinaviska Enskilda Banken AB publ Has $6.99 Million Holdings in Summit Therapeutics PLC $SMMT

Skandinaviska Enskilda Banken AB publ grew its position in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) by 409.2% in the 3rd quarter, according to the company in its most recent Form 13F...

Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026

Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) will host an earnings call to announce its fourth quarter and full year 2025 financial results and provide an operational update...

Summit Therapeutics (SMMT) to Release Earnings on Monday

Summit Therapeutics (NASDAQ:SMMT) will be releasing its Q4 2025 earnings before the market opens on Monday, February 23. (View Earnings Report at...

MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?

Merck stock has risen more than 7% in a month on a stronger long-term outlook, but 2026 headwinds, Keytruda patent risk and Gardasil slump keep it a Sell.

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034)  DelveInsight

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast...

Summit Therapeutics PLC (NASDAQ:SMMT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Summit Therapeutics PLC (NASDAQ:SMMT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seventeen ratings firms that are covering the company, MarketBeat.com...

Summit Therapeutics (NASDAQ:SMMT) Rating Lowered to Strong Sell at Zacks Research

Zacks Research lowered shares of Summit Therapeutics from a "hold" rating to a "strong sell" rating in a research note on Wednesday...

Summit Therapeutics (NASDAQ:SMMT) Reaches New 12-Month Low - Should You Sell?

Summit Therapeutics (NASDAQ:SMMT) Reaches New 52-Week Low - Here's Why...

2 Stocks That Could Soar This Year

Key PointsExelixis and Summit Therapeutics could have significant catalysts this year...

Yong Rong HK Asset Management Ltd Invests $2.07 Million in Summit Therapeutics PLC $SMMT

Yong Rong HK Asset Management Ltd bought a new stake in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought...

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

SMMT
Summit Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SMMT News

SMMTSummit Therapeutics Inc